CoChat

Clinical and cost-effectiveness of nurse-delivered sleep restriction therapy for insomnia in primary care (HABIT): a pragmatic, superiority, open-label, randomised controlled trial

Kyle, Simon D, Siriwardena, A Niroshan, Espie, Colin A, Yang, Yaling, Petrou, Stavros, Ogburn, Emma, Begum, Nargis, Maurer, Leonie F, Robinson, Barbara, Gardner, Caroline, Lee, Victoria, Armstrong, Stephanie, Pattinson, Julie, Mort, Sam, Temple, Eleanor, Harris, Victoria, Yu, Ly-Mee, Bower, Peter, Aveyard, Paul · 2023 · The Lancet
Cited by 79

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Insomnia is prevalent and distressing but access to the first-line treatment, cognitive behavioural therapy (CBT), is extremely limited. We aimed to assess the clinical and cost-effectiveness of sleep restriction therapy, a key component of CBT, which has the potential to be widely implemented. METHODS: We did a pragmatic, superiority, open-label, randomised controlled trial of sleep restriction therapy versus sleep hygiene. Adults with insomnia disorder were recruited from 35 general practices across England and randomly assigned (1:1) using a web-based randomisation programme to either four sessions of nurse-delivered sleep restriction therapy plus a sleep hygiene booklet or a sleep hygiene booklet only. There was no restriction on usual care for either group. Outcomes were assessed at 3 months, 6 months, and 12 months. The primary endpoint was self-reported insomnia severity at 6 months measured with the insomnia severity index (ISI). The primary analysis included participants according to their allocated group and who contributed at least one outcome measurement. Cost-effectiveness was evaluated from the UK National Health Service and personal social services perspective and expressed in terms of incremental cost per quality-adjusted life year (QALY) gained. The trial was prospectively registered (ISRCTN42499563). FINDINGS: Between Aug 29, 2018, and March 23, 2020 we randomly assigned 642 participants to sleep restriction therapy (n=321) or sleep hygiene (n=321). Mean age was 55·4 years (range 19-88), with 489 (76·2%) participants being female and 153 (23·8%) being male. 580 (90·3%) participants provided data for at least one outcome measurement. At 6 months, mean ISI score was 10·9 (SD 5·5) for sleep restriction therapy and 13·9 (5·2) for sleep hygiene (adjusted mean difference -3·05, 95% CI -3·83 to -2·28; p<0·0001; Cohen's d -0·74), indicating that participants in the sleep restriction therapy group reported lower insomnia severity than the sleep hygiene group. The incremental cost per QALY gained was £2076, giving a 95·3% probability that treatment was cost-effective at a cost-effectiveness threshold of £20 000. Eight participants in each group had serious adverse events, none of which were judged to be related to intervention. INTERPRETATION: Brief nurse-delivered sleep restriction therapy in primary care reduces insomnia symptoms, is likely to be cost-effective, and has the potential to be widely implemented as a first-line treatment for insomnia disorder. FUNDING: The National Institute for Health and Care Research Health Technology Assessment Programme.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(23)00683-9

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Research works printed but not linked: 19

  1. Riemann, 2022, Insomnia disorder: state of the science and challenges for the future, J Sleep Res, 31, 10.1111/jsr.13604 · DOI · Paper page
  2. Maire, 2020, Prevalence and management of chronic insomnia in Swiss primary care: cross-sectional data from the “Sentinella” practice-based research network, J Sleep Res, 29, 10.1111/jsr.13121 · DOI
  3. Maurer, 2018, How does sleep restriction therapy for insomnia work? A systematic review of mechanistic evidence and the introduction of the Triple-R model, Sleep Med Rev, 42, 127, 10.1016/j.smrv.2018.07.005 · DOI
  4. Maurer, 2021, The clinical effects of sleep restriction therapy for insomnia: a meta-analysis of randomised controlled trials, Sleep Med Rev, 58, 10.1016/j.smrv.2021.101493 · DOI · Paper page
  5. Falloon, 2015, Simplified sleep restriction for insomnia in general practice: a randomised controlled trial, Br J Gen Pract, 65, e508, 10.3399/bjgp15X686137 · DOI · Paper page
  6. Espie, 2007, Randomized clinical effectiveness trial of nurse-administered small-group cognitive behavior therapy for persistent insomnia in general practice, Sleep, 30, 574, 10.1093/sleep/30.5.574 · DOI · Paper page
  7. Cheung, 2019, A systematic review of cognitive behavioral therapy for insomnia implemented in primary care and community settings, Sleep Med Rev, 44, 23, 10.1016/j.smrv.2018.11.001 · DOI · Paper page
  8. Kyle, 2020, Primary care treatment of insomnia: study protocol for a pragmatic, multicentre, randomised controlled trial comparing nurse-delivered sleep restriction therapy to sleep hygiene (the HABIT trial), BMJ Open, 10, 10.1136/bmjopen-2019-036248 · DOI
  9. Espie, 2014, The Sleep Condition Indicator: a clinical screening tool to evaluate insomnia disorder, BMJ Open, 4, 10.1136/bmjopen-2013-004183 · DOI · Paper page
  10. Buysse, 1989, The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research, Psychiatry Res, 28, 193, 10.1016/0165-1781(89)90047-4 · DOI · Paper page
  11. Kyle, 2013, The Glasgow Sleep Impact Index (GSII): a novel patient-centred measure for assessing sleep-related quality of life impairment in insomnia disorder, Sleep Med, 14, 493, 10.1016/j.sleep.2012.10.023 · DOI
  12. Reilly, 1993, The validity and reproducibility of a work productivity and activity impairment instrument, Pharmacoeconomics, 4, 353, 10.2165/00019053-199304050-00006 · DOI · Paper page
  13. Rabin, 2001, EQ-5D: a measure of health status from the EuroQol Group, Ann Med, 33, 337, 10.3109/07853890109002087 · DOI · Paper page
  14. Yang, 2014, Effect of adding a sleep dimension to the EQ-5D descriptive system: a “bolt-on” experiment, Med Decis Making, 34, 42, 10.1177/0272989X13480428 · DOI · Paper page
  15. Brazier, 2002, The estimation of a preference-based measure of health from the SF-36, J Health Econ, 21, 271, 10.1016/S0167-6296(01)00130-8 · DOI · Paper page
  16. White, 2011, Strategy for intention to treat analysis in randomised trials with missing outcome data, BMJ, 342, d40, 10.1136/bmj.d40 · DOI · Paper page
  17. Adan, 1991, Horne & Östberg morningness-eveningness questionnaire: a reduced scale, Pers Indiv Diff, 12, 241, 10.1016/0191-8869(91)90110-W · DOI · Paper page
  18. Van der Zweerde, 2020, Nurse-guided internet-delivered cognitive behavioral therapy for insomnia in general practice: results from a pragmatic randomized clinical trial, Psychother Psychosom, 89, 174, 10.1159/000505600 · DOI · Paper page
  19. Kyle, 2011, No pain, no gain: an exploratory within-subjects mixed-methods evaluation of the patient experience of sleep restriction therapy (SRT) for insomnia, Sleep Med, 12, 735, 10.1016/j.sleep.2011.03.016 · DOI · Paper page

Cited by

See all 79

Metadata

Authors
Kyle, S. D., Siriwardena, A. N., Espie, C. A., Yang, Y., Petrou, S., Ogburn, E., Begum, N., Maurer, L. F., Robinson, B., Gardner, C., Lee, V., Armstrong, S., Pattinson, J., Mort, S., Temple, E., Harris, V., Yu, L.-M., Bower, P., & Aveyard, P.
Venue
The Lancet
Publisher
Elsevier BV
Published
2023-09
Volume
402
Issue
10406
Pages
975-987
ISSN
0140-6736
Cited by
79
References
19
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Clinical and cost-effectiveness of nurse-delivered sleep restriction therapy for insomnia in primary care (HABIT): a pragmatic, superiority, open-label, randomised controlled trial. https://app.cochat.ai/papers/10.1016/s0140-6736(23)00683-9
The paper
Kyle, S. D., Siriwardena, A. N., Espie, C. A., Yang, Y., Petrou, S., Ogburn, E., Begum, N., Maurer, L. F., Robinson, B., Gardner, C., Lee, V., Armstrong, S., Pattinson, J., Mort, S., Temple, E., Harris, V., Yu, L.-M., Bower, P., & Aveyard, P. (2023). Clinical and cost-effectiveness of nurse-delivered sleep restriction therapy for insomnia in primary care (HABIT): a pragmatic, superiority, open-label, randomised controlled trial. The Lancet. https://doi.org/10.1016/s0140-6736(23)00683-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.